Stock screenerAll disclosures →
EDGAR →
CHRS
Conviction 42HealthcareScan · Fri, Jun 26, 2026CHRS$1.49+0.68%
ResistanceSupportVol 14Vol MA14 855.7K
Mar 27Apr 15May 4May 20Jun 9Jun 26
Price1.49
Change+0.68%
Gap+0.68%
Rel volume2.72×
Avg volume900.47K
Avg $ vol1.33M
SMA 201.46
SMA 501.62
SMA 2001.61
Price vs 50-8.16%
Price vs 200-7.45%
MA stackmixed
50/200 cross—
Supertrenddown · 1.63
RSI (14)48
MACD hist0.02
MACD crossbull · 5d
Stoch %K / %D68 / 68
ADX (14)12
+DI / −DI22 / 19
RSI divergence—
MACD divergence—
ATR %+6.19%
ADR %5.76%
52w high2.51
52w low0.7313
From 52w high-40.64%
Above 52w low+103.75%
New 52w highNo
SqueezeOff
Bollinger width18.50%
%B0.60
Donchian pos46.38%
Donchian high1.68
Donchian low1.33
AVWAP (52w high)1.80
vs AVWAP high-17.05%
AVWAP (52w low)1.56
vs AVWAP low-4.79%
OBV trendFlat
Chaikin MF (20)-0.28
Today vs 20d2.72×
Avg vol (14d)855.7K
Avg vol (20d)900.47K
Avg $ vol (20d)1.33M
Market cap—
RS 3m (vs SPY)-28.18%
RS 6m (vs SPY)-1.51%
RS line new highNo
Trend template3/8
Technical rank39.5
1 week+0.68%
1 month-10.24%
3 months-10.24%
6 months+12.88%
1 year+106.66%
YTD+8.76%
P/E1.36
P/B2.90
P/S—
P/FCF-1.64
EPS1.43
Div yield—
ROE213.71%
ROA63.16%
Debt/Eq0.94
Current1.56
EV/EBITDA-1.04
Gross margin—
Net margin—
Rev growth-100.00%
EPS growth489.41%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value186.71M
Revenue1.4M
Net income-38.33M
Gross profit—
Free cash flow-138.8M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out154.25M
Employees145
ListedThu, Nov 6, 2014
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction42 / 100
Pattern quality—
Tech rank39.5 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.99
Support1.33
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CHRS
No recent disclosed trades by Congress in CHRS. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in CHRS · 10 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
O'Donnell-Tormey Jill Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 60K | $0 | 2026-06-05 | 2026-06-09 |
Wahlstrom Mats Director · Common Stock · 2026-06-05 | Grant | 30K | $0 | 2026-06-05 | 2026-06-09 |
Karachun Rita A Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 60K | $0 | 2026-06-05 | 2026-06-09 |
Wahlstrom Mats Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 60K | $0 | 2026-06-05 | 2026-06-09 |
Newcomer Lee Nisley Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 60K | $0 | 2026-06-05 | 2026-06-09 |
Satvat Ali J. Director · Common Stock · 2026-06-05 | Grant | 30K | $0 | 2026-06-05 | 2026-06-09 |
Newton Charles W. Director · Common Stock · 2026-06-05 | Grant | 30K | $0 | 2026-06-05 | 2026-06-09 |
Satvat Ali J. Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 60K | $0 | 2026-06-05 | 2026-06-09 |
Ryan Michael Lee Director · Common Stock · 2026-06-05 | Grant | 30K | $0 | 2026-06-05 | 2026-06-09 |
Newton Charles W. Director · Stock Option (Right to Buy) · 2026-06-05 | Grant | 60K | $0 | 2026-06-05 | 2026-06-09 |
SEC filings
EDGAR filings in CHRS · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.